Recent events
Recent events tied to this brand in public sources.
Back to profile6 entries
2021
Illumina appoints Bob Ragusa as GRAIL CEO
Illumina announced that Bob Ragusa was appointed Chief Executive Officer of GRAIL, effective immediately. Hans Bishop stepped down and was to serve as an advisor through the end of 2021.
2021
Illumina completes acquisition of Grail
Illumina announced that it had completed its acquisition of cancer-screening company Grail for $8 billion while U.S. and European regulatory reviews were ongoing. The article also reports that the U.S. Federal Trade Commission had opposed the transaction, alleging it could weaken innovation in U.S. multi-cancer early-detection technology.
2021
FTC sues to block Illumina’s acquisition of Grail
The U.S. Federal Trade Commission filed a lawsuit seeking to block Illumina’s acquisition of Grail. The FTC said the acquisition could hinder innovation in multi-cancer detection; this is the regulator’s stated concern, not a court determination.
2020
Illumina announces acquisition of Grail
Illumina announced an $8 billion cash-and-stock acquisition of cancer-screening startup Grail, describing the deal as its entry into the early cancer screening field.
2019
GRAIL announces Matthew Young’s appointment to COO and CFO roles
GRAIL announced on October 8, 2019, that Matthew P. Young would become its Chief Operating Officer and Chief Financial Officer effective October 28, 2019.
2019
GRAIL appoints Marissa Song as General Counsel and Corporate Secretary
GRAIL announced the appointment of Marissa Song as its General Counsel and Corporate Secretary, responsible for overseeing its legal and corporate compliance functions.